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Abstract
Necrotizing fasciitis (NF) is uncommon and difficult to diagnose, and it cause progressive morbidity
until the infectious process is diagnosed and treated medically and surgically. The literature
addressed NF contains confusing information, inaccurate bacteriologic data, and antiquated
antibiotic therapy. A delay in diagnosis is associated with a grave prognosis and increased mortality.
The main goal of the clinician must be to establish the diagnosis and initially treat the patient within
the standard of care. This review is planned as a guide for the clinician in making an early diagnosis
of NF and initiating effective medical and surgical therapy.
Background
Necrotising fasciitis (NF) is a rare soft tissue infection, pri-
marily involving the superficial fascia and resulting in
extensive undermining of the surrounding tissues. If
untreated, it is invariably fatal, and thus a high index of
suspicion for the diagnosis is required [1]. Mortality
remains still high in NF despite use of modern powerful
antimicrobial drug regimens and advances in the care of
the critically ill patients. Overall mortality ranges from 25
percent to 73 percent in the published literature [2-12].
The disease's manifestation can range from a fulminant
presentation to a subtle and insidious development [13].
Historical Perspective
In 1871, a Confederate army surgeon named Joseph Jones
first described the disease during the Civil War. By 1918,
the cause of the disease was identified as a bacterial infec-
tion. It was named "necrotizing fasciitis" in 1952, from
necrosis, which means death of a portion of tissue, and fas-
cia, which refers to the fibrous tissues that enclose and
connect the muscles. Throughout the 19th and 20th cen-
turies, cases of NF occurred only sporadically and usually
remained restricted to military hospitals during wartime,
although some civilian population outbreaks have also
occurred. The Center for Disease Control and Prevention
(CDC) reports that, worldwide, rates of NF increased from
the mid-1980s to early 1990s. Increases in the rate and
severity of NF are associated with increases in the preva-
lence of toxin-producing strains of S. pyogenes (M-1 and
M-3 serotypes). In 1999, approximately 600 cases of NF
were reported in the United States, according to the CDC
[14].
Diagnosis
The diagnosis of primary or idiopathic NF may be chal-
lenging because it occurs in the absence of a known caus-
ative factor or portal of entry for bacteria [11,15]. In most
cases, NF occurs as a result of a known etiology, and clas-
sified as secondary NF. Bacterial entry occurs as a result of
some precipitating events such as laceration, cut, abra-
sion, contusion, burn, bite, subcutaneous injection, or
operative incision, that cause a break in the epidermidis.
Secondary NF may also occur as a result of an occult infec-
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tion such as a perforated viscus or as a complication of
peri-rectal abscess or infected Bartholin cysts [16].
Primary or idiopathic NF, however, occurs in the absence
of a known or identifiable etiologic factor. The underlying
pathogenesis of idiopathic NF is still unknown. In terms
of early diagnosis and management, it is important to
consider that idiopathic NF exists, and that it is a distinct
clinical entity.
The following symptoms of NF were compiled from the
Center for Disease Control and Prevention and the
National Necrotizing Fasciitis Foundation:
Early symptoms (usually within 24 hours):
1. Usually a minor trauma or other skin opening has
occurred (the wound does not necessarily appear
infected)
2. Some pain in the general area of the injury is present.
Not necessarily at the site of the injury but in the same
region or limb of the body
3. The pain is usually disproportionate to the injury and
may start as something akin to a muscle pull, but becomes
more and more painful
4. Flu like symptoms begin to occur, such as diarrhea,
nausea, fever, confusion, dizziness, weakness, and general
malaise
5. Dehydration
6. The biggest symptom is all of these symptoms com-
bined. In general you will probably feel worse than you've
ever felt and not understand why.
Advanced symptoms (usually within 3–4 days):
1. The limb, or area of body experiencing pain begins to
swell, and may show a purplish rash
2. The limb may begin to have large, dark marks, that will
become blisters filled with blackish fluid
3. The wound may actually begin to appear necrotic with
a bluish, white, or dark, mottled, flaky appearance.
Critical symptoms (usually within 4–5 days):
1. Blood pressure will drop severely
2. The body begins to go into septic shock from the toxins
the bacteria are giving off
3. Unconsciousness will occur as the body becomes too
weak to fight off this infection.
DM is the leading predisposing factor in both idiopathic
and secondary NF in our patient population. The mecha-
nisms that has been suggested how DM could cause sus-
ceptibility to NF are: a) The peripheral sensory
polyneuropathy experienced by diabetics may increase
susceptibility to minor trauma. b) tissue hypoxia caused
by diabetic vascular disease and the underlying immuno-
deficiency [17]. Even though there is substantial evidence
indicating an important role of DM in the etiology of NF,
its role as a predisposing factor for increased death rate is
controversial. Some reports failed to show a significant
relationship between mortality and DM in NF [9,18].
Interestingly, however, DM was determined as a signifi-
cant factor associated with mortality in multivariate anal-
ysis in our study.
Immuno-competence has been claimed to be an impor-
tant factor in the etiopathogenesis of NF [19]. Sudarsky et
al reported that 91% of their patients with NF had some
associated immunodeficiency [20]. These predisposing
conditions are mainly DM, alcoholism, end-stage renal
disease, malignancy, chemotherapy, malnutrition, corti-
costeroid use, multitrauma and the peripartum period
[8,9,21].
Prevention
The following is a list of recommendations to prevent the
disease, as reported by the CDC.
￿ Good hand washing can prevent the spread of Group A
Streptococcus (GAS) infection, especially after coughing,
sneezing and before preparing food or eating.
￿ Patients with sore throats should be seen by a doctor.
￿ Patients with strep throat should stay home until 24
hours after their last antibiotic dose.
￿ Keeping the skin intact is important.
￿ Wounds should be cleaned and monitored for signs of
infection (redness, swelling, drainage, pain).
￿ Keeping the skin intact is an important factor in prevent-
ing NF.
￿ Patients with an infected wound and fever should seek
medical care.World Journal of Emergency Surgery 2007, 2:19 http://www.wjes.org/content/2/1/19
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Treatment
The treatment for NF is a combination of surgical debride-
ment, appropriate antibiotics and optimal oxygenation of
the infected tissues.
NF a challenging and potentially lethal disease; early diag-
nosis is of principal importance and aggressive multidisci-
plinary treatment is mandatory. Early recognition and
treatment by extensive debridement and antibiotics can
prevent its fulminant course with a fatal outcome
[8,9,11]. The priority in every case is to proceed to radical
surgical debridement.
Once NF diagnosed all patients must be treated with
immediate surgical debridement, and broad spectrum
antibiotic combinations against the anaerobs, gram-nega-
tive and gram-positive bacilli, that were changed to other
antibiotic combinations as determined according to the
culture sensitivity of the microbial isolates and clinical
course of the patients.
The microbiological isolates were polibacterial in the
majority of the patients with either idiopathic or second-
ary NF in concordance with some recent studies [5,18,19].
Therefore, administration of broad-spectrum antibiotics
appears to be important in the management of these
patients.
Penicillin-clindamycin-gentamicin or ampicillin/sul-
bactam or nafcillin or cefazolin plus metronidazol combi-
nations could be considered in the initial antibiotherapy
of NF according to the physician's preference. If ESBL-pro-
ducing  K. pneumoniae susceptible to beta-lactam/beta-
lactamase inhibitor combinations was identified (i.e, pip-
eracillin/tazobactam, ticarcillin/clavulanate), one of these
antibiotics or carbapenems in combination with
aminoglycosides could be preferred. If Clostridium perfrin-
gens was suspected or identified, aqueous penicillin G (18
million units/day, if renal function is normal) was admin-
istered with or without hyperbaric oxygen-therapy.
Hyperbaric oxygen therapy (HBO) treatment increase tis-
sue oxygenation in both healthy tissue and in the vicinity
of infected tissue [22-24]. Hyperbaric oxygen-therapy was
administered at 2.5 to 3.0 atmospheres for 90 min twice
daily, following surgical debridement until no ongoing
necrosis was evident in patients with clostridial infections.
Critical care support was provided for patients with hemo-
dynamic and ventilatory instability.
Elderly patients with underlying DM that have suspicious
clinical findings of NF without any causative factors (e.g.
trauma or operation) should be carefully be examined for
the presence of idiopathic NF. The mortality rates are still
very high in NF due to the severe sepsis that necessitates
other interventions to overcome sepsis-related mortality.
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